For various keratoconus & infectious keratitis settings.
Thickness-adjusted ProfileBeam profile delivers more energy in the corneal periphery.
Superior Battery TechnologyBuilt to last for thousands of treatments.
Wheelchair AccessibleConveniently treat wheelchair users.
For modern CXL: fits on Haag Streit and Zeiss design-slit lamps.
Table MountFor classic CXL: table mount accessory available.
Integrated ProtocolsChoose from a number of preset clinical protocols.
Range of IntensitiesDelivers 3, 9, 15, 18 and 30 mW/cm².
The C-eye device is CE marked for the following indications: keratoconus, ectasia after LASIK/PRK, pellucid marginal degeneration, infectious keratitis, sterile corneal melting, bullous keratopathy. The C-eye is not available for sale in the United States.
EMAGine's C-eye device brings cross-linking technology to the slit lamp. Simple, efficient and safe from the novice to the expert user.
Perform CXL at the slit lamp. Or use the C-eye device just like any other CXL device: on a table mount, in your operating room.
Work in different places? Take the C-eye device wherever you go. Charge it via USB-C, with your smartphone charger, or your laptop.
Reduces time and costs related to performing CXL
Remember that every cross-linking procedure not only improves biomechanics, it also “disinfects” the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is “sterile”. And by the way: office-based cataract surgery and office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach here.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not “care” whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon’s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see here.
Find more answers in our FAQ section.
The most versatile and comprehensive CXL technology available.
The C-eye device fits to a number of Haag-Streit and Zeiss type slit lamps. Find here the complete list of compatible slit lamps
One Riboflavin for
Keratoconus and Keratitis
EMAGine’s Medical Director, Prof. Farhad Hafezi, and its CEO, Nikki Hafezi, presented remotely at the CXL Experts’ Summer Meeting 2023,
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News
The advantages of performing corneal cross-linking (CXL) at the slit lamp are well established. It brings CXL out of the
It has been quite the debate. Should surgeons drop riboflavin onto the cornea during the UV irradiation part of a
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
January 21, 2022
NUHS 36th Anniversary Conference
Location: Singapore
Language: English
January 15, 2022
Muscat International Ophthalmology Conference (MIOC)
Location: Muscat, Oman
Language: English
December 4, 2021
Kölner Adventssymposium 2021
Location: Köln, Germany
Language: German
November 25, 2021
Middle East Africa Council of Ophthalmology
Location: Dubai, UAE
Language: English
November 18, 2021
14th World Down Syndrome Congress
Location: Dubai, UAE
Language: English
November 11, 2021
La Société Marocaine de la chirurgie réfractive
Location: Rabat, Morocco
Language: French
November 4, 2021
Sorocaba Eye Bank
Location: Brazil
Language: English
October 28, 2021
Emirates Society Of Ophthalmology
Location: Dubai, UAE
Language: English
October 23, 2021
LV Prasad Eye Institute
Location: Hyderabad, India
Language: English
October 23, 2021
65th Brazilian Congress of Ophthalmology
Location: Natal, Brazil
Language: English
